Headlines

NHTSA announced it is expanding its investigation into potentially defective airbags that may fail to deploy in a wreck and that have caused at least eight deaths in the United States. The airbags may not deploy due to “electrical overstress.”

Allegations were recently raised that in the midst of VW’s attempts to restore broken trust, the company and its subsidiary Audi were secretly lying to customers and regulators by selling pre-production vehicles to the public that legally should have been headed for the junkyard. It’s a classic case of irony.

Motley Rice is co-class counsel in the case in which plaintiffs allege Twitter Inc. knowingly concealed and made false statements about key operating metrics, allegedly in violation of the federal securities laws.

One hundred and forty-nine passengers and eight crew members were killed when their plane, Ethiopian Airlines Flight 302, crashed. The plane, a new Boeing 737 MAX 8, was en route to Nairobi, Kenya, and carrying passengers of 35 different nationalities.

Oklahoma Attorney General announced a settlement in the opioid litigation with Purdue Pharma and the Sackler family. This is a significant step in the effort of the governmental entities to address the opioid epidemic.

U.S. District Judge Mary Scriven has allowed plaintiffs to move forward with allegations that the cancer care company jeopardized the private health information of millions of patients by failing to prevent a data breach.

American Honda recently announced a recall of 1.1 million vehicles due to a defective airbag inflators. This recall is for replacement airbags that were previously installed in the vehicles in the wake of the Takata airbag scandal.

Recognizing his work representing plaintiffs, the Roger Williams University School of Law named attorney Robert McConnell one of its 2019 Champions for Justice.

The U.S. Supreme Court is expected this term to resolve conflicting opinions in False Claims Act (FCA) whistleblower litigation regarding whether an extended statute of limitations should apply to cases in which the government declines to intervene.

Claims alleging anti-nausea medication Zofran® caused life-threatening birth defects in unborn children will be allowed to move forward following a ruling Feb. 5, 2019 denying summary judgment.